ClinicalTrials.gg
Not yet recruitingNCT07948850RUTBEUpdated Nov 19, 2026

Effects of Psychosocial Skills Training on Self-Stigma and Forgiveness Among Caregivers of Individuals With Psychotic Disorders

An interventional study of Psychosocial Skills Training (RUTBE) in Psychotic Disorders, Self-stigma and Forgiveness, sponsored by Ömer USLU. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Ömer USLU · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 19 studies in Psychotic Disorders with a site in Turkey — 5 open to participants now, 6 under way, 1 of them phase 3. Psychotic Disorders · Turkey.

Planned enrollment
10th of 13
34 · median 50
Started
2026
with 5 others
No phase
9 of 19
3 open now
Registered
19th of 19
by date

Among the 19 studies in Psychotic Disorders with a site in Turkey, this one is the 10th largest by planned enrollment of the 13 interventional ones that give a count, is one of 6 that started in 2026, is one of 9 with no phase, and was the 19th registered.

Psychotic Disorders

1,591 studies on the registry are indexed under Psychotic Disorders; 282 are open to participants now.

Browse Psychotic Disorders studies →

Open to participants now

5 of the 19 studies in Psychotic Disorders with a site in Turkey are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 205 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 143 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Psychotic Disorders with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effects of psychosocial skills training on self-stigma and forgiveness among family caregivers of individuals with psychotic disorders. Caring for a person with a long-term mental illness can create emotional and social challenges. Family caregivers may experience stigma, difficulties in social relationships, and challenges related to forgiveness.

The study will include 34 adult caregivers who will be randomly assigned to an intervention group (n=17) or a control group (n=17). The intervention group will receive an eight-session, face-to-face psychosocial skills training program delivered once a week. The program will focus on understanding mental illness, improving communication and problem-solving skills, supporting treatment, managing persistent symptoms, coping with stress, and strengthening social functioning. The control group will not receive the training during the study period.

Self-stigma and forgiveness will be assessed in both groups before the intervention, immediately after the eight-session program, and three months after the intervention. The findings will help determine whether psychosocial skills training can reduce self-stigma and improve forgiveness among caregivers of individuals with psychotic disorders.

Read the detailed description

This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effects of psychosocial skills training on self-stigma and forgiveness among caregivers of individuals diagnosed with psychotic disorders. The study will be conducted at the Community Mental Health Center affiliated with Söke Fehime Faik Kocagöz State Hospital in Aydın, Türkiye.

A total of 34 caregivers will be recruited and randomly allocated to an intervention group (n=17) or a control group (n=17) using randomizer.org. Eligible participants will be adults aged 18 years or older who are literate and provide care to an individual diagnosed with a psychotic or schizophrenia spectrum disorder according to DSM-5 criteria. Caregivers whose conditions substantially interfere with effective communication will not be eligible. Participation will be voluntary, and informed consent will be obtained before data collection.

The intervention group will participate in a structured psychosocial skills training program based on the principles of Liberman's Social and Independent Living Skills Program and the training manual developed by Yıldız. The program will consist of eight weekly, face-to-face group sessions lasting approximately 90-120 minutes each. The sessions will address group preparation and communication, understanding mental illness and daily living skills, cognitive and perceptual disturbances, treatment and medication management, coping with persistent symptoms and early warning signs, avoiding harmful or ineffective treatments, stress management and self-confidence, and social functioning. Interactive discussions, practical exercises, and homework assignments will be used to support learning and application of skills. Homework reminders may be provided by telephone calls or messages.

The control group will not receive the structured psychosocial skills training during the intervention and follow-up periods. Following completion of the three-month follow-up assessment, the training will also be offered to the control group.

Data will be collected at three time points: baseline, immediately after completion of the eight-session intervention, and three months after the intervention. The Self-Stigma Scale-Family Form will be used to assess caregivers' self-stigma, and the Forgiveness Scale will be used to assess forgiveness. A personal information form will be administered at baseline to collect sociodemographic characteristics.

The study will compare changes in self-stigma and forgiveness scores between the intervention and control groups over time. The findings are expected to provide evidence regarding the potential benefits of structured psychosocial skills training for caregivers of individuals with psychotic disorders.

03

Conditions studied

  • Psychotic Disorders
  • Self-stigma
  • Forgiveness

Browse trials for

Keywords

  • Family Caregivers, Psychosocial Skills Training, Psychoeducation, Affiliate Stigma, Forgiveness, Community Mental Health, Randomized Controlled Trial
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older.
  • Being a family caregiver of an individual diagnosed with a psychotic or schizophrenia spectrum disorder.
  • Being able to read and write.
  • Being willing to participate in the study and providing .

Exclusion criteria

Exclusion Criteria:

  • Having a condition that prevents effective communication or participation in the study procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    Participants in this group will receive an eight-session, face-to-face psychosocial skills training program delivered once weekly. Each session will last approximately 90-120 minutes.

    Behavioral: Psychosocial Skills Training (RUTBE)

  • No intervention
    Control Group

    Participants in this group will not receive the structured psychosocial skills training program during the intervention and follow-up periods. The training will be offered after completion of the three-month follow-up assessment.

Interventions

  • BehavioralPsychosocial Skills Training (RUTBE)

    The intervention consists of eight weekly, face-to-face psychosocial skills training sessions for family caregivers of individuals with psychotic disorders. Each session will last approximately 90-120 minutes. The program focuses on mental illness awareness, communication, problem-solving, treatment support, symptom management, stress management, and social functioning.

06

What researchers measure

Primary outcomes

  1. Change in Caregiver Self-Stigma

    Caregiver self-stigma will be assessed using the Self-Stigma Scale-Family Form, a 14-item instrument rated on a five-point Likert scale. Changes in self-stigma scores will be compared between the intervention and control groups across three assessment points.

    Time frame: Baseline, immediately after the 8-week intervention, and 3 months after the intervention

  2. Change in Caregiver Forgiveness

    Forgiveness will be assessed using the Forgiveness Scale, a 13-item instrument rated on a seven-point Likert scale. Changes in forgiveness scores will be compared between the intervention and control groups across three assessment points.

    Time frame: Baseline, immediately after the 8-week intervention, and 3 months after the intervention

07

Study locations

1 site
  • Söke Fehime Faik Kocagöz State Hospital - Community Mental Health Center
    Aydin, SÖKE 09200, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers due to the sensitive nature of the psychosocial information collected from family caregivers of individuals with psychotic disorders and the need to protect participant confidentiality and privacy. Study findings will be reported in aggregate form without identifying individual participants.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for May 2027, 5 months later.

Of 459 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 5 months is below that.

Counting every sponsor, half of 461 studies reached it within 34 months; a quarter within 19 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2026
First posted
Nov 19, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948850
Lead sponsor
Ömer USLU
Responsible party
Ömer USLU (Dr. Ömer Uslu, PhD - Principal Investigator, Aydin Adnan Menderes University) — Sponsor-investigator
First posted
Nov 19, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Ömer USLU, PhD
Contact
imerr.uslu@gmail.com
+905418217957
Hava Salık, PhD
principal investigator · Hakkari University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion